Immortalized Mouse Podocytes-SV40 (MPC-5)

Immortalized Mouse Podocytes-SV40 (MPC-5)

Cat.No.: CSC-I2320Z

Species: Mouse

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I2320Z
Description
The conditionally Immortalized Mouse Podocytes-SV40 cell line allows an in-vitro process of maturation analogous to the development and maturation of podocytes in-vivo. Both proliferating
and differentiating MPC cells express the WT-1 protein and an ordered array of actin fibres and microtubules extends into the forming cellular processes during differentiation, reminiscent of
podocyte processes in vivo. The result is a homogenous, stable cell source that shows expression of key antigenic markers of differentiated in-vivo podocytes. These include the novel podocyte
proteins nephrin, podocin, CD2AP and synaptopodin.

Immortalization is conditional by use of a temperature-sensitive transgene encoding SV40LT.
Species
Mouse
Recommended Medium
Immortalized Mouse Podocyte Medium (CM-I2320Z)
Freezing Medium
Complete medium supplemented with 10% (v/v) DMSO
Culture Properties
Adherent
Immortalization Method
a temperature-sensitive transgene encoding SV40LT
Shipping
Dry Ice
Quality Control
Real Time PCR was used to quantify SV40T gene expression in immortalized cell line.
free from contaminations (bacteria incl. mycoplasma, fungi, HIV, HAV, HBV, HCV, Parvo-B19) and cross-contaminations
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20°C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Immortalized Mouse Podocytes (MPC-5) represent the gold-standard conditionally immortalized podocyte model, originally established in 1997 from glomeruli of the H-2Kb-tsA58 mice. The line harbors a temperature-sensitive SV40 large T antigen driven by an interferon-γ–inducible promoter, enabling reversible switching between proliferation and differentiation.

This conditional system uniquely overcomes the central limitations of primary podocytes—replicative senescence, rapid dedifferentiation, and short in vitro lifespan—while preserving faithful recapitulation of in vivo podocyte biology. Differentiated MPC-5 robustly express the full complement of podocyte-specific markers, including WT-1, synaptopodin, nephrin, podocin, and CD2AP, together with slit diaphragm components (ZO-1, catenins, P-cadherin) and physiologically relevant signaling responses such as bradykinin-B2–mediated electrophysiology.

Extensively validated across transcriptomic, cytoskeletal, and functional assays, MPC-5 has been instrumental in elucidating mechanisms of diabetic nephropathy, podocyte injury, and glomerular filtration barrier pathophysiology. The line supports facile genetic manipulation (transfection, siRNA, CRISPR/Cas9) and is authenticated by STR profiling. By delivering unlimited expandability, experimental consistency, and a differentiation trajectory that mirrors physiological podocyte maturation, MPC-5 remains the most widely adopted and rigorously characterized platform for mechanistic and therapeutic research in glomerular disease.

Formononetin Inhibits p53 Signaling Pathway Activation to Delay Cellular Senescence

This study aimed to evaluate the efficacy of formononetin (FN) using an in vitro model of high glucose (HG)-induced injury in MPC-5 podocytes. Transcriptomic profiling was employed to assess the influence of FN on global gene expression and to identify key signaling pathways affected by FN treatment.

In the HG-induced MPC-5 cell model, FN treatment significantly enhanced cell viability and reduced the secretion of senescence-associated secretory phenotype (SASP) factors in the supernatant. Transcriptomic analysis revealed the p53 signaling pathway as a central target of FN under HG conditions. FN treatment markedly suppressed β-galactosidase (β-GAL) activity, upregulated the expression of MDM2 and CCND1, downregulated the expression of p53 and p21, and inhibited p53 transcriptional activity in MPC-5 cells. In diabetic kidney disease (DKD) mice, FN administration improved renal function, alleviated histopathological damage, reduced renal SASP levels and β-GAL activity, and normalized the expression of key proteins in the p53 pathway.

FN intervention delays senescence of MPC-5 cells via the p53 signaling pathway.
Fig. 1. Formononetin intervention delays senescence of MPC-5 cells via p53 signaling pathway (Ji, Yue, et al., 2026).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products